Executive Overview Testing for homologous recombination deficiency (HRD) has emerged as a cornerstone of personalized oncology, particularly in the management...
Executive Overview In a milestone development for computational pathology and cancer diagnostics, an international research team has introduced an advanced...
Oral squamous cell carcinoma (OSCC) represents one of the most formidable and prevalent malignancies affecting the head and neck region....
Executive Overview For decades, the mainstream neuroscientific consensus framed Alzheimer’s disease primarily through the lens of protein aggregation—specifically, the extracellular...
Executive Overview In an era defined by rapid technological disruption in healthcare, clinical laboratories find themselves at a critical crossroads....
Executive Overview Dementia currently casts a long and lengthening shadow over global public health, affecting approximately 55 million people worldwide—a...
Executive Overview In the rapidly evolving landscape of modern healthcare, diagnostic pathology stands at a historic crossroads. For over two...
Executive Overview Eosinophilic esophagitis (EoE)—a chronic, immune-mediated inflammatory condition of the esophagus driven by allergens and type 2 immune responses—has...
Rare cancers represent a profound challenge in modern oncology. While individually uncommon, they collectively account for 20% to 25% of...
Executive Overview In the ongoing war against cancer, early and accurate diagnosis remains the single most effective weapon. For decades,...
Executive Overview The COVID-19 pandemic served as an unprecedented crucible for global healthcare systems, forcing a rapid, radical reimagining of...
Executive Overview Artificial intelligence has rapidly transformed from a futuristic ambition into a foundational infrastructure across modern biomedical sciences. Among...
